113 related articles for article (PubMed ID: 24294959)
21. The association of mammalian DREAM complex and HPV16 E7 proteins.
Rashid NN; Rothan HA; Yusoff MS
Am J Cancer Res; 2015; 5(12):3525-33. PubMed ID: 26885443
[TBL] [Abstract][Full Text] [Related]
22. The Rb binding domain of HPV31 E7 is required to maintain high levels of DNA repair factors in infected cells.
Johnson BA; Aloor HL; Moody CA
Virology; 2017 Jan; 500():22-34. PubMed ID: 27770701
[TBL] [Abstract][Full Text] [Related]
23. Pocket proteins suppress head and neck cancer.
Shin MK; Pitot HC; Lambert PF
Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
[TBL] [Abstract][Full Text] [Related]
24. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
[TBL] [Abstract][Full Text] [Related]
25. Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer.
Tzenov YR; Andrews PG; Voisey K; Popadiuk P; Xiong J; Popadiuk C; Kao KR
Mol Cancer Res; 2013 Jan; 11(1):19-30. PubMed ID: 23284001
[TBL] [Abstract][Full Text] [Related]
26. Type 2 human papillomavirus E7 attenuates E-cadherin expression in human keratinocytes.
Song JY; Park YM; Choi SY
J Microbiol; 2021 Jun; 59(6):616-625. PubMed ID: 33779957
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
28. Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.
Genovese NJ; Broker TR; Chow LT
J Virol; 2011 Jun; 85(11):5546-54. PubMed ID: 21411531
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.
Grace M; Munger K
Virology; 2017 Jan; 500():71-81. PubMed ID: 27771561
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members.
Duensing S; Münger K
J Virol; 2003 Nov; 77(22):12331-5. PubMed ID: 14581569
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus and molecular considerations for cancer risk.
Whiteside MA; Siegel EM; Unger ER
Cancer; 2008 Nov; 113(10 Suppl):2981-94. PubMed ID: 18980282
[TBL] [Abstract][Full Text] [Related]
32. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
Heck DV; Yee CL; Howley PM; Münger K
Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
[TBL] [Abstract][Full Text] [Related]
33. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T
J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
[TBL] [Abstract][Full Text] [Related]
35. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
36. Papillomavirus E6 and E7 proteins and their cellular targets.
Wise-Draper TM; Wells SI
Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
[TBL] [Abstract][Full Text] [Related]
37. High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
Wallace NA; Khanal S; Robinson KL; Wendel SO; Messer JJ; Galloway DA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768872
[TBL] [Abstract][Full Text] [Related]
38. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
40. Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers.
Pannone G; Santoro A; Carinci F; Bufo P; Papagerakis SM; Rubini C; Campisi G; Giovannelli L; Contaldo M; Serpico R; Mazzotta M; Lo Muzio L
Int J Immunopathol Pharmacol; 2011; 24(2 Suppl):95-101. PubMed ID: 21781453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
